{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:56:45Z","timestamp":1792202205349,"version":"4.4.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T00:00:00Z","timestamp":1449532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00415-015-7967-1","type":"journal-article","created":{"date-parts":[[2015,12,9]],"date-time":"2015-12-09T03:44:47Z","timestamp":1449632687000},"page":"861-870","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Cardiovascular adverse effects of phenytoin"],"prefix":"10.1007","volume":"263","author":[{"given":"B.","family":"Guldiken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"R\u00e9mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheyl","family":"Noachtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,8]]},"reference":[{"key":"7967_CR1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/epi.12074","volume":"54","author":"T Glauser","year":"2013","unstructured":"Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Guerreiro C, K\u00e4lvi\u00e4inen R, Mattson R, French JA, Perucca E, Tomson T (2013) Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 54:551\u2013563","journal-title":"Epilepsia"},{"key":"7967_CR2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1468-1331.2009.02917.x","volume":"17","author":"H Meierkord","year":"2010","unstructured":"Meierkord H, Boon P, Engelsen B, G\u00f6cke K, Shorvon S, Tinuper P, Holtkamp M (2010) EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 17:348\u2013355","journal-title":"Eur J Neurol"},{"key":"7967_CR3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0002-8703(76)80223-2","volume":"91","author":"S Zoneraich","year":"1976","unstructured":"Zoneraich S, Zoneraich O, Siegel J (1976) Sudden death following intravenous sodium diphenylhydantoin. Am Heart J 91:375\u2013377","journal-title":"Am Heart J"},{"key":"7967_CR4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0002-8703(67)90082-8","volume":"74","author":"AW Goldschlager","year":"1967","unstructured":"Goldschlager AW, Karliner JS (1967) Ventricular standstill after intravenous diphenylhydantoin. Am Heart J 74:410\u2013412","journal-title":"Am Heart J"},{"key":"7967_CR5","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1001\/jama.1968.03150090194036","volume":"206","author":"MA Russell","year":"1968","unstructured":"Russell MA, Bousvaros G (1968) Fatal results from diphenylhydantoin administered intravenously. JAMA 206:2118\u20132119","journal-title":"JAMA"},{"key":"7967_CR6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jama.1967.03120170107029","volume":"200","author":"AH Unger","year":"1967","unstructured":"Unger AH, Sklaroff HJ (1967) Fatalities following intravenous use of sodium diphenylhydantoin for cardiac arrhythmias. Report of two cases. JAMA 200:335\u2013336","journal-title":"JAMA"},{"key":"7967_CR7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jama.1967.03120170109030","volume":"200","author":"GL Gellerman","year":"1967","unstructured":"Gellerman GL, Martinez C (1967) Fatal ventricular fibrillation following intravenous sodium diphenylhydantoin therapy. JAMA 200:337\u2013338","journal-title":"JAMA"},{"key":"7967_CR8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.seizure.2007.04.012","volume":"16","author":"P Agarwal","year":"2007","unstructured":"Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg N (2007) Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 16:527\u2013532","journal-title":"Seizure"},{"key":"7967_CR9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/ane.12174","volume":"129","author":"C Kellinghaus","year":"2014","unstructured":"Kellinghaus C, Berning S, St\u00f6gbauer F (2014) Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus. Acta Neurol Scand 129:294\u2013299","journal-title":"Acta Neurol Scand"},{"key":"7967_CR10","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.annemergmed.2003.10.011","volume":"43","author":"MI Rudis","year":"2004","unstructured":"Rudis MI, Touchette DR, Swadron SP, Chiu AP, Orlinsky M (2004) Cost-effectiveness of oral phenytoin, intravenous phenytoin, and intravenous fosphenytoin in the emergency department. Ann Emerg Med 43:386\u2013387","journal-title":"Ann Emerg Med"},{"key":"7967_CR11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12028-009-9304-y","volume":"12","author":"JP Szaflarski","year":"2010","unstructured":"Szaflarski JP, Sangha KS, Lindsell CJ, Shutter LA (2010) Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Neurocrit Care 12:165\u2013172","journal-title":"Neurocrit Care"},{"key":"7967_CR12","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.ajem.2010.05.005","volume":"29","author":"PM Aaronson","year":"2011","unstructured":"Aaronson PM, Belgado BS, Spillane JP, Kunisaki TA (2011) Evaluation of intramuscular fosphenytoin vs intravenous phenytoin loading in the ED. Am J Emerg Med 29:983\u2013989","journal-title":"Am J Emerg Med"},{"key":"7967_CR13","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0149-2918(96)80051-8","volume":"18","author":"A Marchetti","year":"1996","unstructured":"Marchetti A, Magar R, Fischer J, Sloan E, Fischer P (1996) A pharmacoeconomic evaluation of intravenous fosphenytoin (Cerebyx@) versus intravenous phenytoin (Dilantin@) in hospital emergency departments. Clin Ther 18:953\u2013966","journal-title":"Clin Ther"},{"key":"7967_CR14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.pediatrneurol.2011.07.007","volume":"45","author":"A Rai","year":"2011","unstructured":"Rai A, Aggarwal A, Mittal H, Sharma S (2011) Comparative efficacy and safety of intravenous valproate and phenytoin in children. Pediatr Neurol 45:300\u2013304","journal-title":"Pediatr Neurol"},{"key":"7967_CR15","first-page":"S216","volume":"4","author":"A Chitsaz","year":"2013","unstructured":"Chitsaz A, Mehvari J, Salari M, Gholami F, Najafi M-R (2013) A comparative assessment the efficacy of intravenous infusion of sodium valproate and phenytoin in the treatment of status epilepticus. Int J Prev Med 4:S216\u2013S221","journal-title":"Int J Prev Med"},{"key":"7967_CR16","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/01.wnl.0000224880.35053.26","volume":"67","author":"UK Misra","year":"2006","unstructured":"Misra UK, Kalita J, Patel R (2006) Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology 67:340\u2013342","journal-title":"Neurology"},{"key":"7967_CR17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1600-0404.2008.01097.x","volume":"118","author":"R Gilad","year":"2008","unstructured":"Gilad R, Izkovitz N, Dabby R, Rapoport A, Sadeh M, Weller B, Lampl Y (2008) Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin. Acta Neurol Scand 118:296\u2013300","journal-title":"Acta Neurol Scand"},{"key":"7967_CR18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jocn.2011.07.021","volume":"19","author":"K Kern","year":"2012","unstructured":"Kern K, Schebesch KM, Schlaier J, Hansen E, Feigl GC, Brawanski AT, Lange M (2012) Levetiracetam compared to phenytoin for the prevention of postoperative seizures after craniotomy for intracranial tumours in patients without epilepsy. J Clin Neurosci 19:99\u2013100","journal-title":"J Clin Neurosci"},{"key":"7967_CR19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1528-1167.2012.03563.x","volume":"54","author":"KL Fuller","year":"2013","unstructured":"Fuller KL, Wang YY, Cook MJ, Murphy MA, D\u2019Souza WJ (2013) Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study. Epilepsia 54:45\u201357","journal-title":"Epilepsia"},{"key":"7967_CR20","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","volume":"339","author":"DM Treiman","year":"1998","unstructured":"Treiman DM, Meyers PD, Walton NY et al (1998) A comparison of four treatments for generalized convulsive status epilepticus. Veterans affairs status epilepticus cooperative study group. N Engl J Med 339:792\u2013798","journal-title":"N Engl J Med"},{"key":"7967_CR21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0022-3565(25)23279-7","volume":"120","author":"DW Esplin","year":"1957","unstructured":"Esplin DW (1957) Effects of diphenylhydantoin on synaptic transmission in cat spinal cord and stellate ganglion. J Pharmacol Exp Ther 120:301\u2013323","journal-title":"J Pharmacol Exp Ther"},{"key":"7967_CR22","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0026-895X(25)09256-9","volume":"42","author":"J Francis","year":"1992","unstructured":"Francis J, Burnham WM (1992) [3H]Phenytoin identifies a novel anticonvulsant-binding domain on voltage-dependent sodium channels. Mol Pharmacol 42:1097\u20131103","journal-title":"Mol Pharmacol"},{"key":"7967_CR23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0022-3565(25)11757-6","volume":"118","author":"WA Dill","year":"1956","unstructured":"Dill WA, Glazko AJ, Kazenko A, Wolf LM (1956) Studies on 5, 5\u2032-diphenylhydantoin (dilantin) in animals and man. J Pharmacol Exp Ther 118:270\u2013279","journal-title":"J Pharmacol Exp Ther"},{"key":"7967_CR24","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/cpt1976193360","volume":"19","author":"BJ Wilder","year":"1976","unstructured":"Wilder BJ, Ramsay RE (1976) Oral and intramuscular phenytoin. Clin Pharmacol Ther 19:360\u2013364","journal-title":"Clin Pharmacol Ther"},{"key":"7967_CR25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1553-2712.2004.tb02204.x","volume":"11","author":"SP Swadron","year":"2004","unstructured":"Swadron SP, Rudis MI, Azimian K, Beringer P, Fort D, Orlinsky M (2004) A comparison of phenytoin-loading techniques in the emergency department. Acad Emerg Med 11:244\u2013252","journal-title":"Acad Emerg Med"},{"key":"7967_CR26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-510X(96)05314-2","volume":"147","author":"D Ratanakorn","year":"1997","unstructured":"Ratanakorn D, Kaojarern S, Phuapradit P, Mokkhavesa C (1997) Single oral loading dose of phenytoin: a pharmacokinetics study. J Neurol Sci 147:89\u201392","journal-title":"J Neurol Sci"},{"key":"7967_CR27","unstructured":"Morita DA GT (2006) Phenytoin and fosphenytoin. In: Wyllie Elaine (ed) Treat. Epilepsie, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 785\u2013803"},{"key":"7967_CR28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1385\/NCC:3:2:161","volume":"3","author":"S Craig","year":"2005","unstructured":"Craig S (2005) Phenytoin poisoning. Neurocrit Care 3:161\u2013170","journal-title":"Neurocrit Care"},{"key":"7967_CR29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1684\/epd.2014.0714","volume":"16","author":"G Zaccara","year":"2014","unstructured":"Zaccara G, Tion C, Perucca E (2014) Seminar in epileptology interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs. Epileptic Disord Epileptic Disord Epileptic Disord 16:409\u2013432","journal-title":"Epileptic Disord Epileptic Disord Epileptic Disord"},{"key":"7967_CR30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/archsurg.1978.01370150017002","volume":"113","author":"BA Bivins","year":"1978","unstructured":"Bivins BA, Rapp RP, Griffen WO, Blouin R, Bustrack J (1978) Dopamine-phenytoin interaction. A cause of hypotension in the critically ill. Arch Surg 113:245\u2013249","journal-title":"Arch Surg"},{"key":"7967_CR31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0735-6757(88)90012-5","volume":"6","author":"RC York","year":"1988","unstructured":"York RC, Coleridge ST (1988) Cardiopulmonary arrest following intravenous phenytoin loading. Am J Emerg Med 6:255\u2013259","journal-title":"Am J Emerg Med"},{"key":"7967_CR32","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0002-8703(67)90205-0","volume":"73","author":"RD Conn","year":"1967","unstructured":"Conn RD, Kennedy JW, Blackmon JR (1967) The hemodynamic effects of diphenylhydantoin. Am Heart J 73:500\u2013505","journal-title":"Am Heart J"},{"key":"7967_CR33","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1212\/WNL.28.9.874","volume":"28","author":"RE Cranford","year":"1978","unstructured":"Cranford RE, Leppik IE, Patrick B, Anderson CB, Kostick B (1978) Intravenous phenytoin: clinical and pharmacokinetic aspects. Neurology 28:874\u2013880","journal-title":"Neurology"},{"key":"7967_CR34","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0002-8703(67)90011-7","volume":"74","author":"S Louis","year":"1967","unstructured":"Louis S, Kutt H, McDowell F (1967) The cardiocirculatory changes caused by intravenous dilantin and its solvent. Am Heart J 74:523\u2013529","journal-title":"Am Heart J"},{"key":"7967_CR35","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/bja\/58.8.897","volume":"58","author":"D Al-Khudhairi","year":"1986","unstructured":"Al-Khudhairi D, Whitwam JG (1986) Autonomic reflexes and the cardiovascular effects of propylene glycol. Br J Anaesth 58:897\u2013902","journal-title":"Br J Anaesth"},{"key":"7967_CR36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM196502112720602","volume":"272","author":"RD Conn","year":"1965","unstructured":"Conn RD (1965) Diphenylhydantoin sodium in cardiac arrythmias. N Engl J Med 272:277\u2013282","journal-title":"N Engl J Med"},{"key":"7967_CR37","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1378\/chest.51.3.256","volume":"51","author":"JS Karliner","year":"1967","unstructured":"Karliner JS (1967) Intravenous diphenylhydantoin sodium (Dilantin) in cardiac arrhythmias. Dis Chest 51:256\u2013269","journal-title":"Dis Chest"},{"key":"7967_CR38","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0002-9149(67)90011-2","volume":"20","author":"M Rosen","year":"1967","unstructured":"Rosen M, Lisak R, Rubin IL (1967) Diphenylhydantoin in cardiac arrhythmias. Am J Cardiol 20:674\u2013678","journal-title":"Am J Cardiol"},{"key":"7967_CR39","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0196-0644(84)80063-3","volume":"13","author":"B Carducci","year":"1984","unstructured":"Carducci B, Hedges JR, Beal JC, Levy RC, Martin M (1984) Emergency phenytoin loading by constant intravenous infusion. Ann Emerg Med 13:1027\u20131031","journal-title":"Ann Emerg Med"},{"key":"7967_CR40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0196-0644(05)81211-9","volume":"20","author":"PJ Donovan","year":"1991","unstructured":"Donovan PJ, Cline D (1991) Phenytoin administration by constant intravenous infusion: selective rates of administration. Ann Emerg Med 20:139\u2013142","journal-title":"Ann Emerg Med"},{"key":"7967_CR41","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(58)92407-3","volume":"2","author":"PK McWilliam","year":"1958","unstructured":"McWilliam PK (1958) Intravenous phenytoin sodium in continuous convulsions in children. Lancet 2:1147\u20131149","journal-title":"Lancet"},{"key":"7967_CR42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2377-13-98","volume":"13","author":"S Tiamkao","year":"2013","unstructured":"Tiamkao S, Sawanyawisuth K, Chancharoen A (2013) The efficacy of intravenous sodium valproate and phenytoin as the first-line treatment in status epilepticus: a comparison study. BMC Neurol 13:98","journal-title":"BMC Neurol"},{"key":"7967_CR43","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/adc.2011.215269","volume":"96","author":"DB Hawcutt","year":"2011","unstructured":"Hawcutt DB, Sampath S, Timmis A, Newland V, Newland P, Appleton R (2011) Serum phenytoin concentrations in paediatric patients following intravenous loading. Arch Dis Child 96:883\u2013884","journal-title":"Arch Dis Child"},{"key":"7967_CR44","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/archdischild-2013-305093","volume":"99","author":"JD Piper","year":"2014","unstructured":"Piper JD, Hawcutt DB, Verghese GK, Spinty S, Newland P, Appleton R, Hey A (2014) Phenytoin dosing and serum concentrations in paediatric patients requiring 20\u00a0mg\/kg intravenous loading. Arch Dis Child 99:585\u2013586","journal-title":"Arch Dis Child"},{"key":"7967_CR45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.0269-4727.2003.00506.x","volume":"28","author":"EF Martinelli","year":"2003","unstructured":"Martinelli EF, M\u00fchlebach SF (2003) Rapid i.v. loading with phenytoin with subsequent dose adaptation using non-steady-state serum levels and a Bayesian forecasting computer program to predict maintenance doses. J Clin Pharm Ther 28:385\u2013393","journal-title":"J Clin Pharm Ther"},{"key":"7967_CR46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/bmj.3.5716.203","volume":"3","author":"AJ Handley","year":"1970","unstructured":"Handley AJ (1970) Phenytoin tolerance tests. Br Med J 3:203\u2013204","journal-title":"Br Med J"},{"key":"7967_CR47","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1553-2712.1995.tb03633.x","volume":"2","author":"H Schmidt","year":"1995","unstructured":"Schmidt H, Belleza J, Dougherty Lynn White JM, Robin Lammers M (1995) Adverse Effects associated with phenytoin administration. Acad Emerg Med 2:758\u2013759","journal-title":"Acad Emerg Med"},{"key":"7967_CR48","first-page":"S49","volume":"57","author":"W Wallis","year":"2001","unstructured":"Wallis W, Kutt H, McDowell F (2001) Intravenous diphenylhydantoin in treatment of acute repetitive seizures. 1968. Neurology 57:S49\u2013S61","journal-title":"Neurology"},{"key":"7967_CR49","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(87)90603-9","volume":"1","author":"RM Slater","year":"1987","unstructured":"Slater RM, Smith WD, Patrick J, Mawer GE, Wilcox FL, Donnai P, Richardson T, D\u2019Souza SW, Anderton JM (1987) Phenytoin infusion in severe pre-eclampsia. Lancet 1:1417\u20131421","journal-title":"Lancet"},{"key":"7967_CR50","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0196-0644(05)81606-3","volume":"20","author":"JF Chance","year":"1991","unstructured":"Chance JF (1991) Emergency department treatment of alcohol withdrawal seizures with phenytoin. Ann Emerg Med 20:520\u2013522","journal-title":"Ann Emerg Med"},{"key":"7967_CR51","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1059-1311(02)00338-2","volume":"12","author":"RE Appleton","year":"2003","unstructured":"Appleton RE, Gill A (2003) Adverse events associated with intravenous phenytoin in children: a prospective study. Seizure 12:369\u2013372","journal-title":"Seizure"},{"key":"7967_CR52","first-page":"354","volume":"38","author":"RB Salem","year":"1981","unstructured":"Salem RB, Wilder BJ, Yost RL, Doering PL, Lee C (1981) Rapid infusion of phenytoin sodium loading doses. Am J Hosp Pharm 38:354\u2013357","journal-title":"Am J Hosp Pharm"},{"key":"7967_CR53","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1528-1157.2002.24801.x","volume":"43","author":"A Santis De","year":"2002","unstructured":"De Santis A, Villani R, Sinisi M, Stocchetti N, Perucca E (2002) Add-on phenytoin fails to prevent early seizures after surgery for supratentorial brain tumors: a randomized controlled study. Epilepsia 43:175\u2013182","journal-title":"Epilepsia"},{"key":"7967_CR54","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0090-3019(89)90067-0","volume":"31","author":"ST Lee","year":"1989","unstructured":"Lee ST, Lui TN, Chang CN, Cheng WC, Wang DJ, Heimburger RF, Lin CG (1989) Prophylactic anticonvulsants for prevention of immediate and early postcraniotomy seizures. Surg Neurol 31:361\u2013364","journal-title":"Surg Neurol"},{"key":"7967_CR55","first-page":"185","volume":"10","author":"B Young","year":"1983","unstructured":"Young B, Rapp RP, Norton JA, Haack D, Walsh JW (1983) Failure of prophylactically administered phenytoin to prevent post-traumatic seizures in children. Childs Brain 10:185\u2013192","journal-title":"Childs Brain"},{"key":"7967_CR56","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0147-9563(97)90090-X","volume":"26","author":"ML Evers","year":"1997","unstructured":"Evers ML, Izhar A, Aqil A (1997) Cardiac monitoring after phenytoin overdose. Hear Lung J Acute Crit Care 26:325\u2013328","journal-title":"Hear Lung J Acute Crit Care"},{"key":"7967_CR57","first-page":"164","volume":"31","author":"DL Curtis","year":"1989","unstructured":"Curtis DL, Piibe R, Ellenhorn MJ, Wasserberger J, Ordog G (1989) Phenytoin toxicity: a review of 94 cases. Vet Hum Toxicol 31:164\u2013165","journal-title":"Vet Hum Toxicol"},{"key":"7967_CR58","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0196-0644(05)81604-X","volume":"20","author":"CD Wyte","year":"1991","unstructured":"Wyte CD, Berk WA (1991) Severe oral phenytoin overdose does not cause cardiovascular morbidity. Ann Emerg Med 20:508\u2013512","journal-title":"Ann Emerg Med"},{"key":"7967_CR59","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jama.1983.03330300046032","volume":"249","author":"MP Earnest","year":"1983","unstructured":"Earnest MP, Marx JA, Drury LR (1983) Complications of intravenous phenytoin for acute treatment of seizures. Recommendations for usage. JAMA 249:762\u2013765","journal-title":"JAMA"},{"key":"7967_CR60","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1528-1157.2001.29300.x","volume":"42","author":"JC DeToledo","year":"2001","unstructured":"DeToledo JC, Lowe MR, Rabinstein A, Villaviza N (2001) Cardiac arrest after fast intravenous infusion of phenytoin mistaken for fosphenytoin. Epilepsia 42:288","journal-title":"Epilepsia"},{"key":"7967_CR61","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-0736(05)80287-0","volume":"28","author":"DN Randazzo","year":"1995","unstructured":"Randazzo DN, Ciccone A, Schweitzer P, Winters SL (1995) Complete atrioventricular block with ventricular asystole following infusion of intravenous phenytoin. J Electrocardiol 28:157\u2013159","journal-title":"J Electrocardiol"},{"key":"7967_CR62","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00008506-199901000-00008","volume":"11","author":"JM Berry","year":"1999","unstructured":"Berry JM, Kowalski A, Fletcher SA (1999) Sudden asystole during craniotomy: unrecognized phenytoin toxicity. J Neurosurg Anesthesiol 11:42\u201345","journal-title":"J Neurosurg Anesthesiol"},{"key":"7967_CR63","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4103\/0028-3886.51296","volume":"57","author":"C-H Lu","year":"2009","unstructured":"Lu C-H, Su C-M, Kung C-T, Wang Y-C (2009) Life-threatening cardiotoxicity due to chronic oral phenytoin overdose. Neurol India 57:200","journal-title":"Neurol India"},{"key":"7967_CR64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/cpt1976192135","volume":"19","author":"R Gugler","year":"1976","unstructured":"Gugler R, Manion CV, Azarnoff DL (1976) Phenytoin: pharmacokinetics and bioavailability. Clin Pharmacol Ther 19:135\u2013142","journal-title":"Clin Pharmacol Ther"},{"key":"7967_CR65","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1001\/archinte.159.22.2639","volume":"159","author":"PD Meek","year":"2015","unstructured":"Meek PD, Davis SN, Collins DM, Gidal BE (2015) Guidelines for nonemergency use of parenteral phenytoin products. Arc Intern Med 159:2639\u20132644","journal-title":"Arc Intern Med"},{"key":"7967_CR66","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0735-6757(96)90059-5","volume":"14","author":"L Binder","year":"1996","unstructured":"Binder L, Trujillo J, Parker D, Guetter A (1996) Association of intravenous phenytoin toxicity with demographic, clinical, and dosing parameters. Am J Emerg Med 14:398\u2013401","journal-title":"Am J Emerg Med"},{"key":"7967_CR67","author":"K Prasad","year":"2005","unstructured":"Prasad K, Al-Roomi K, Krishnan PR, Sequeira R (2005) Anticonvulsant therapy for status epilepticus. Cochrane Database Syst Rev. doi: 10.1002\/14651858.CD003723","journal-title":"Cochrane Database Syst Rev"},{"key":"7967_CR68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1445-5994.2012.02935.x","volume":"43","author":"WJ Siebert","year":"2013","unstructured":"Siebert WJ, McGavigan AD (2013) Requirement for cardiac telemetry during intravenous phenytoin infusion: guideline fact or guideline fiction? Intern Med J 43:7\u201317","journal-title":"Intern Med J"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7967-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-015-7967-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7967-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T18:04:14Z","timestamp":1748714654000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-015-7967-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,8]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["7967"],"URL":"https:\/\/doi.org\/10.1007\/s00415-015-7967-1","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,8]]}}}